Skip to main content
Erschienen in: AIDS and Behavior 7/2021

05.01.2021 | Original Paper

Examining the Factors Affecting PrEP Implementation Within Community-Based HIV Testing Sites in Florida: A Mixed Methods Study Applying the Consolidated Framework for Implementation Research

verfasst von: DeAnne Turner, Elizabeth Lockhart, Wei Wang, Robert Shore, Ellen Daley, Stephanie L. Marhefka

Erschienen in: AIDS and Behavior | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

HIV testing/counseling is a critical point during which non-clinical staff could intervene, discuss and/or refer clients for pre-exposure prophylaxis (PrEP). This analysis investigated the contextual factors affecting PrEP implementation within HIV testing sites. Two generalized linear mixed models were conducted to estimate PrEP implementation as a function of constructs from the Consolidated Framework for Implementation Research (CFIR). Qualitative interviews were analyzed thematically. Data integration occurred via joint analysis and triangulation. Constructs from the CFIR domain Characteristics of Individuals did not predict PrEP implementation when controlling for demographic characteristics; qualitative data signaled divergent findings in PrEP knowledge. Within the CFIR domains Inner and Outer Settings, relevant priority and available resources predicted PrEP implementation; qualitative data confirmed the importance of available resources and provided insight into the impact of cosmopolitanism and leadership. Addressing the contextual factors that affect PrEP implementation may help HIV testing staff to better implement PrEP programs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink HJ, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44(2):151–8.CrossRef Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink HJ, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44(2):151–8.CrossRef
2.
Zurück zum Zitat Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra25.CrossRef Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra25.CrossRef
4.
Zurück zum Zitat World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva, Switzerland: World Health Organization; 2015. p. 2. Report No. WHO/HIV/2015.48. World Health Organization. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva, Switzerland: World Health Organization; 2015. p. 2. Report No. WHO/HIV/2015.48.
5.
Zurück zum Zitat World Health Organization. Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva, Switzerland: World Health Organization; 2012. p.19. ISBN: 978 92 4 150388 4. World Health Organization. Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva, Switzerland: World Health Organization; 2012. p.19. ISBN: 978 92 4 150388 4.  
6.
Zurück zum Zitat World Health Organization. Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. Geneva, Switzerland: World Health Organization; 2012. p. 79. ISBN 978 92 4 150197 2. World Health Organization. Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach. Geneva, Switzerland: World Health Organization; 2012. p. 79. ISBN 978 92 4 150197 2.  
8.
Zurück zum Zitat The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: Updated to 2020. In: Policy OoNA, editor. Washington, D.C.2015. The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: Updated to 2020. In: Policy OoNA, editor. Washington, D.C.2015.
9.
Zurück zum Zitat U.S. Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States –2014 clinical providers’ Supplement 2014. U.S. Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States –2014 clinical providers’ Supplement 2014.
11.
Zurück zum Zitat Krakower DS, Mayer KH. The role of healthcare providers in the roll-out of PrEP. Curr Opin HIV AIDS. 2016;11(1):41.CrossRef Krakower DS, Mayer KH. The role of healthcare providers in the roll-out of PrEP. Curr Opin HIV AIDS. 2016;11(1):41.CrossRef
12.
Zurück zum Zitat Smith DK, Maier E, Betts J, Gray S, Kolodziejski B, Hoover KW. What community-based HIV prevention organizations say about their role in biomedical HIV prevention. AIDS Educ Prev. 2016;28(5):426–39.CrossRef Smith DK, Maier E, Betts J, Gray S, Kolodziejski B, Hoover KW. What community-based HIV prevention organizations say about their role in biomedical HIV prevention. AIDS Educ Prev. 2016;28(5):426–39.CrossRef
13.
Zurück zum Zitat Krakower DS, Jain S, Mayer KH. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep. 2015;12(1):127–38.CrossRef Krakower DS, Jain S, Mayer KH. Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis. Curr HIV/AIDS Rep. 2015;12(1):127–38.CrossRef
14.
Zurück zum Zitat Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016;11(1):41–8.CrossRef Krakower DS, Mayer KH. The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2016;11(1):41–8.CrossRef
15.
Zurück zum Zitat Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7(6):593–9.CrossRef Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7(6):593–9.CrossRef
16.
Zurück zum Zitat Mayer KH, Chan PA, Patel RR, Flash CA, Krakower DS. Evolving models and ongoing challenges for HIV preexposure prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr. 2018;77(2):119–27.CrossRef Mayer KH, Chan PA, Patel RR, Flash CA, Krakower DS. Evolving models and ongoing challenges for HIV preexposure prophylaxis Implementation in the United States. J Acquir Immune Defic Syndr. 2018;77(2):119–27.CrossRef
17.
Zurück zum Zitat Smith DK, Dearing JW, Sanchez T, Goldschmidt RH. Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S. Am J Prev Med. 2013;44(1 Suppl 2):S59-62.CrossRef Smith DK, Dearing JW, Sanchez T, Goldschmidt RH. Introducing wicked issues for HIV pre-exposure prophylaxis implementation in the U.S. Am J Prev Med. 2013;44(1 Suppl 2):S59-62.CrossRef
18.
Zurück zum Zitat Underhill K, Morrow KM, Colleran CM, Holcomb R, Operario D, Calabrese SK, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE. 2014;9(11):e112425.CrossRef Underhill K, Morrow KM, Colleran CM, Holcomb R, Operario D, Calabrese SK, et al. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US. PLoS ONE. 2014;9(11):e112425.CrossRef
19.
Zurück zum Zitat Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep. 2010;7(4):210–9.CrossRef Underhill K, Operario D, Mimiaga MJ, Skeer MR, Mayer KH. Implementation science of pre-exposure prophylaxis: preparing for public use. Curr HIV/AIDS Rep. 2010;7(4):210–9.CrossRef
20.
Zurück zum Zitat Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K. Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr. 2010;55(1):8–13.CrossRef Underhill K, Operario D, Skeer M, Mimiaga M, Mayer K. Packaging PrEP to prevent HIV: an integrated framework to plan for pre-exposure prophylaxis implementation in clinical practice. J Acquir Immune Defic Syndr. 2010;55(1):8–13.CrossRef
21.
Zurück zum Zitat FDOH. DH1628 Laboratory request form 2012. FDOH. DH1628 Laboratory request form 2012.
22.
Zurück zum Zitat Parsons JT, John SA, Whitfield THF, Cienfuegos-Szalay J, Grov C. HIV/STI counseling and testing services received by gay and bisexual men using pre-exposure prophylaxis (PrEP) at their last PrEP care visit. Sex Transm Dis. 2018;45:798.CrossRef Parsons JT, John SA, Whitfield THF, Cienfuegos-Szalay J, Grov C. HIV/STI counseling and testing services received by gay and bisexual men using pre-exposure prophylaxis (PrEP) at their last PrEP care visit. Sex Transm Dis. 2018;45:798.CrossRef
23.
Zurück zum Zitat Hevey MA, Walsh JL, Petroll AE. PrEP Continuation, HIV and STI testing rates, and delivery of preventive care in a clinic-based cohort. AIDS Educ Prev. 2018;30(5):393–405.CrossRef Hevey MA, Walsh JL, Petroll AE. PrEP Continuation, HIV and STI testing rates, and delivery of preventive care in a clinic-based cohort. AIDS Educ Prev. 2018;30(5):393–405.CrossRef
24.
Zurück zum Zitat Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, et al. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. J Int AIDS Soc. 2016;19(1):20777.CrossRef Wilton J, Kain T, Fowler S, Hart TA, Grennan T, Maxwell J, et al. Use of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk. J Int AIDS Soc. 2016;19(1):20777.CrossRef
25.
Zurück zum Zitat Kwan TH, Lee SS. Predictors of HIV testing and their influence on PrEP acceptance in men who have sex with men: a cross-sectional study. AIDS Behav. 2018;22(4):1150–7.CrossRef Kwan TH, Lee SS. Predictors of HIV testing and their influence on PrEP acceptance in men who have sex with men: a cross-sectional study. AIDS Behav. 2018;22(4):1150–7.CrossRef
26.
Zurück zum Zitat Flash CA, Adegboyega OO, Yu X, Avalos C, Johnson S, Mayer KH, et al. Correlates of linkage to HIV preexposure prophylaxis among HIV-testing clients. JAIDS J Acquir Immune Defic Syndr. 2018;77(4):365–72.CrossRef Flash CA, Adegboyega OO, Yu X, Avalos C, Johnson S, Mayer KH, et al. Correlates of linkage to HIV preexposure prophylaxis among HIV-testing clients. JAIDS J Acquir Immune Defic Syndr. 2018;77(4):365–72.CrossRef
27.
Zurück zum Zitat Hammack PL, Meyer IH, Krueger EA, Lightfoot M, Frost DM. HIV testing and pre-exposure prophylaxis (PrEP) use, familiarity, and attitudes among gay and bisexual men in the United States: a national probability sample of three birth cohorts. PLoS ONE. 2018;13(9):e0202806.CrossRef Hammack PL, Meyer IH, Krueger EA, Lightfoot M, Frost DM. HIV testing and pre-exposure prophylaxis (PrEP) use, familiarity, and attitudes among gay and bisexual men in the United States: a national probability sample of three birth cohorts. PLoS ONE. 2018;13(9):e0202806.CrossRef
28.
Zurück zum Zitat Turner D, Lockhart E, Wang W, Shore R, Daley EM, Marhefka SL. PrEP implementation behaviors of community-based HIV testing staff: a mixed methods approach using latent class analysis. J Acquir Immune Defic Syndr. 2020;83:467.CrossRef Turner D, Lockhart E, Wang W, Shore R, Daley EM, Marhefka SL. PrEP implementation behaviors of community-based HIV testing staff: a mixed methods approach using latent class analysis. J Acquir Immune Defic Syndr. 2020;83:467.CrossRef
29.
Zurück zum Zitat Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRef Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRef
30.
Zurück zum Zitat Creswell JW. Research design: qualitative, quantitative, and mixed methods approaches. Thousand Oaks: Sage publications; 2013. Creswell JW. Research design: qualitative, quantitative, and mixed methods approaches. Thousand Oaks: Sage publications; 2013.
31.
32.
Zurück zum Zitat Dillman DA. Mail and internet surveys: the tailored design method—2007 update with new internet, visual, and mixed-mode guide. New York: Wiley; 2011. Dillman DA. Mail and internet surveys: the tailored design method—2007 update with new internet, visual, and mixed-mode guide. New York: Wiley; 2011.
33.
Zurück zum Zitat Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, et al. Knowledge is Power! increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–10.CrossRef Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, et al. Knowledge is Power! increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–10.CrossRef
34.
Zurück zum Zitat Walsh JL, Petroll AE. Using the information-motivation-behavioral skills model to predict discussion and prescription of pre-exposure propohylaxis among primary care providers. American Public Health Association 144th Annual Meeting and Expo; November 2, 2016; Denver, CO2016. Walsh JL, Petroll AE. Using the information-motivation-behavioral skills model to predict discussion and prescription of pre-exposure propohylaxis among primary care providers. American Public Health Association 144th Annual Meeting and Expo; November 2, 2016; Denver, CO2016.
35.
Zurück zum Zitat Helfrich CD, Li Y-F, Sharp ND, Sales AE. Organizational readiness to change assessment (ORCA): development of an instrument based on the promoting action on research in health services (PARIHS) framework. Implement Sci. 2009;4(38):38.CrossRef Helfrich CD, Li Y-F, Sharp ND, Sales AE. Organizational readiness to change assessment (ORCA): development of an instrument based on the promoting action on research in health services (PARIHS) framework. Implement Sci. 2009;4(38):38.CrossRef
37.
Zurück zum Zitat Gustafson DH, Sainfort F, Eichler M, Adams L, Bisognano M, Steudel H. Developing and testing a model to predict outcomes of organizational change. Health Serv Res. 2003;38(2):751–76.CrossRef Gustafson DH, Sainfort F, Eichler M, Adams L, Bisognano M, Steudel H. Developing and testing a model to predict outcomes of organizational change. Health Serv Res. 2003;38(2):751–76.CrossRef
38.
Zurück zum Zitat SPSS I. IBM SPSS statistics for Windows, version 20.0. New York: IBM Corp. 2011. SPSS I. IBM SPSS statistics for Windows, version 20.0. New York: IBM Corp. 2011.
39.
Zurück zum Zitat Heck RH, Thomas S, Tabata L. Multilevel modeling of categorical outcomes using IBM SPSS: Routledge; 2013. Heck RH, Thomas S, Tabata L. Multilevel modeling of categorical outcomes using IBM SPSS: Routledge; 2013.
40.
Zurück zum Zitat Kuckartz U. MAXQDA: Qualitative data analysis. Berlin: VERBI software; 2007. Kuckartz U. MAXQDA: Qualitative data analysis. Berlin: VERBI software; 2007.
41.
Zurück zum Zitat Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks: Sage; 2011. Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks: Sage; 2011.
42.
Zurück zum Zitat Creswell JW, Klassen AC, Plano Clark VL, Smith KC. Best practices for mixed methods research in the health sciences. Bethesda, MD: National Institutes of Health; 2011. p. 10. Creswell JW, Klassen AC, Plano Clark VL, Smith KC. Best practices for mixed methods research in the health sciences. Bethesda, MD: National Institutes of Health; 2011. p. 10.
43.
Zurück zum Zitat Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs—principles and practices. Health Serv Res. 2013;48(6pt2):2134–56.CrossRef Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs—principles and practices. Health Serv Res. 2013;48(6pt2):2134–56.CrossRef
44.
Zurück zum Zitat Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013;27(10):553–9.CrossRef Tellalian D, Maznavi K, Bredeek UF, Hardy WD. Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices. AIDS Patient Care STDS. 2013;27(10):553–9.CrossRef
45.
Zurück zum Zitat Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, et al. Putting PrEP into practice: lessons learned from early-adopting US providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS ONE. 2016;11(6):e0157324.CrossRef Calabrese SK, Magnus M, Mayer KH, Krakower DS, Eldahan AI, Gaston Hawkins LA, et al. Putting PrEP into practice: lessons learned from early-adopting US providers’ firsthand experiences providing HIV pre-exposure prophylaxis and associated care. PLoS ONE. 2016;11(6):e0157324.CrossRef
46.
Zurück zum Zitat White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012;26(7):395–405.CrossRef White JM, Mimiaga MJ, Krakower DS, Mayer KH. Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention. AIDS Patient Care STDS. 2012;26(7):395–405.CrossRef
Metadaten
Titel
Examining the Factors Affecting PrEP Implementation Within Community-Based HIV Testing Sites in Florida: A Mixed Methods Study Applying the Consolidated Framework for Implementation Research
verfasst von
DeAnne Turner
Elizabeth Lockhart
Wei Wang
Robert Shore
Ellen Daley
Stephanie L. Marhefka
Publikationsdatum
05.01.2021
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2021
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-020-03152-1

Weitere Artikel der Ausgabe 7/2021

AIDS and Behavior 7/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.